What It Is
PRA-crd3 is a cone-rod dystrophy form of progressive retinal atrophy associated with ADAM9-related retinal degeneration, classically described in the Glen of Imaal Terrier.
Also Called: cone-rod dystrophy 3; crd3; ADAM9-associated PRA
Abbreviation: PRA-crd3
Breeds Affected: Glen of Imaal Terrier
The Idiot-Proof Explanation
This is a specific PRA variant where the retina degenerates and vision declines, often with both cone and rod involvement. Translation: the dog may lose useful vision and breeders need the right genetic test before they make more puppies with the same problem.
What Causes It
PRA-crd3 is associated with a mutation affecting ADAM9 and cone-rod retinal function. It is usually discussed separately because the gene, breed relevance, and test are specific.
Compared with the parent PRA page, the owner experience still centers on progressive vision loss. The subtype details matter most for accurate testing and breeding decisions.
- This is an inherited retinal degeneration.
- Cone-rod involvement means both bright-light and low-light vision can be affected as disease progresses.
- Genetic testing can identify clear, carrier, and affected dogs when the correct breed/test applies.
Bottom line: crd3 is not just “some PRA.” It is a specific variant with specific breeding consequences.
What This Means for Life With This Dog
Owners should prepare for progressive vision issues and a dog that may need more environmental support over time.
Breeders should treat variant testing as serious health screening, not optional alphabet soup.
Can It Be Fixed?
PRA-crd3 cannot be cured. Management focuses on diagnosis, monitoring, home safety, and preventing affected puppies through correct testing.
Symptoms Owners May Notice
Progressive vision loss: The dog may become less confident, misjudge objects, or show worsening vision over time.
Dim-light difficulty: Many PRA-type conditions make night or low-light navigation harder first or early in the course.
Daylight vision changes: Cone-rod disease can also affect brighter-light vision as progression continues.
Retinal thinning or abnormal exam: An ophthalmology exam may find retinal changes before owners fully register how much the dog is compensating.
Treatment Options
Variant-specific DNA testing: Use the correct crd3/ADAM9 test when breed-appropriate. Wrong test, wrong answer. Tiny science lesson, huge breeding consequence.
Eye exams: Veterinary ophthalmology exams help document retinal status and rule out other eye disease.
Blindness safety planning: Use stable furniture layouts, stair gates, leashes, lights, and predictable cues as vision declines.
Recovery and Aftercare
There is no recovery. The aftercare is adaptation, monitoring, and breeding decisions that do not pretend genetics is a rumor.
What Happens If You Wait
Waiting mostly delays responsible decisions.
You cannot reverse inherited retinal degeneration by noticing it late. Delay costs preparation time and can let risky breeding choices continue.
Cost Reality Check
Costs focus on genetic testing, eye exams, and helping the dog adapt to vision loss.
| Care Level | What It May Include | Estimated Cost |
|---|---|---|
| Initial workup | DNA test and baseline eye screening. | $100-$500 |
| Ongoing management | Ophthalmology monitoring and home safety changes. | $300-$1,500+ |
| Severe case | Advanced diagnostics or secondary eye problems. | $1,000-$4,000+ |
Budget Reality Check
| Budget Item | Estimated Cost |
|---|---|
| crd3/ADAM9 genetic test | $60-$250+ |
| Eye screening | $50-$250+ |
| Ophthalmologist consult | $250-$700+ |
Lifetime Cost Reality
| Case Pattern | Possible Lifetime Cost |
|---|---|
| Testing-only case | $60-$500+ |
| Affected dog monitoring | $500-$3,000+ |
| Complicated eye care | $2,000-$6,000+ |
Tell Me What I Should Really Expect
PRA-crd3 is where precise naming actually matters.
The owner needs vision-loss support. The breeder needs the exact test. Calling it generic PRA may be easier, but easier is how preventable inherited disease keeps getting invited back like a terrible houseguest.
